A graduate of Technische Universität Berlin (1994–2001), he relocated to Sweden in the early 2000s, founding his first company in 2002. Since then, Sven’s work has revolved around building intelligent platforms that leverage machine learning, semantic models, and digital twin technology to emulate human reasoning and drive more sustainable practices.
In 2011, he established Scharc Technology, where he continues to serve as CEO, focusing on BIM, digital twins, and AI-driven solutions that streamline project design and delivery in the real estate industry. By 2023, Sven had already ventured into medtech, spearheading the development of a medical AI Q&A prototype in collaboration with a physician at the University Hospital Basel. His commitment to integrating engineered experience feedback across diverse decision-making contexts is evident in his subsequent initiatives within the healthcare sector.
Beyond his entrepreneurial undertakings, Sven fosters the next generation of innovators and has been a Corporate Mentor at Stanford University and is a Mentor at AI Grid Germany. His track record exemplifies how the thoughtful application of advanced technologies can unite sustainable business models with forward-looking solutions that benefit both current and future generations.
She has consistently pushed the boundaries of science and technology and as a former senior scientist specializing in X-ray crystallography and cryoEM, Jola successfully led cross-disciplinary projects that brought together protein scientists, computational chemists, and medicinal chemists to tackle complex challenges in drug discovery.
Her expertise encompasses molecular biology, protein purification, and biophysics, with over 25 scientific publications and multiple protein structure submissions to the Protein Data Bank. Since 2020, Jola has been instrumental in Evotec’s in silico R&D division, leveraging her deep structural biology knowledge to harness cutting-edge machine learning (ML) and artificial intelligence (AI) technologies for generative protein design. Her innovative work includes developing tools for Crystallization Drop Classification and integrating advanced models such as AlphaFold, ProteinMPNN, and RFDiffusion into drug discovery pipelines. Beyond her research contributions, Jola is passionate about fostering technological growth within teams.
She has spearheaded internal Python training programs, established a coding network for the Protein Sciences team, and designed Django + Angular web applications to streamline laboratory workflows. Her commitment to sustainability is equally noteworthy; as a Sustainability Champion for Evotec’s Abingdon site, she has driven initiatives focused on circular economy practices and climate neutrality. Additionally, she holds a Yellow Belt certification in Lean Six Sigma, demonstrating her dedication to operational excellence. Jola’s unique blend of scientific expertise, technological innovation, and leadership makes her a driving force in advancing modern solutions that bridge biology and computational science.
With his expertise and experience as a physician and researcher in experimental and transplantation immunology at Karolinska University Hospital, along with his work at Devyser developing highly sensitive and precise methods for mixed chimerism analysis, he plays a key role in Viska’s mission to develop clinical decision support for transplantation. He is the author or co-author of over 40 peer-reviewed publications and books. His medical expertise is crucial in shaping Viska AI’s new clinical decision support system.
As a UX Designer and Design Manager, Julia has led the development of several medtech software products currently in use globally, meeting regulatory requirements and receiving positive user feedback. She is experienced in driving the full design process – from needs analysis to launch – including user research, personas, wireframes, prototypes, and interface design, always in close collaboration with cross-functional teams. Her goal has consistently been to deliver intuitive, user-friendly products that improve workflows and patient outcomes while meeting the needs of healthcare professionals, decision-makers, and regulatory bodies. Julia works in accordance with international usability standards for medtech, including IEC 62366 (for IVDR) and FDA guidelines for software, making her skillset highly relevant to Viska AI’s development of clinical decision support systems.
With over 20 years of solid experience in research, development, and project management in DNA and molecular diagnostics, he has led the successful development, production, and CE-marking of over 60 medical devices. Two of these, with annual sales exceeding EUR 50 million, were developed for Roche Molecular Systems – one of the global leaders in diagnostics. This expertise is instrumental in shaping and developing Viska’s new decision support system for post-transplantation care.
Dan Hauzenberger and Anders Hedrum collaborated for over 20 years at Devyser, which is now publicly listed on First North Stockholm. Devyser develops, manufactures, and sells genetic tests to laboratories worldwide. Their products are used in oncology, transplantation, and rare disease diagnostics, enabling personalized cancer treatment, genetic diagnostics, and monitoring of transplant patients. Together, they bring a complementary and highly relevant combination of expertise to the development of medtech solutions for healthcare.
